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Summary
Conditioned media obtained from fibroblasts cultured from rheumatoid and certain other
inflammatory synovia were observed to stimulate [3H]thymidine incorporation in an indicator
murine fibroblast line. Synovial fibroblasts derived from thejoints of patients with osteoarthritis
did not display this property. This effect persisted in culture for many weeks and occurred in
the absence of co-stimulatory immune cells. Antibody neutralization studies implicated a role
for basic fibroblast growth factor (bFGF), transforming growth factorQ (TGF-a), granulocyte/
macrophage colony-stimulating factor (GM-CSF), and interleukin 10 (IL1)3) in the increased
proliferative activity of synovial fibroblast-conditioned media . Synovial cell synthesis of bFGF,
TGFa1, GM-CSF, IL10, and 11,6 was confirmed by 31S-methionine labeling and immunopre-
cipitation . The constitutive production of inflammatory and mitogenic cytokiries by synovial
fibroblasts may represent the result oflong-term, phenotypic changes that occurred in vivo. Persistent
cytokine production by synovial fibroblasts may play an important role in the continued recruitment
and activation ofinflammatory cells in chronic arthritis and in the formation of rheumatoid pannus.
C
hronic inflammatory arthritis is characterized by a re-
lapsing and remitting course ofjoint inflammation that
leads ultimately to joint destruction and crippling (1) . The
overlyingjoint capsule or synovium may undergo profound
hypertrophic and proliferative changes during this process.
In rheumatoid arthritis, for example, these changes result in
the formation of synovial pannus, which invades periartic-
ular tissue and causes severe bony and ligamentous destruc-
tion (1) .
The distinctive molecular features that characterize the sy-
novial response to inflammation are poorly understood .
Monocyte-derived products such as IL-1 and TNF/cachectin
stimulate synovial fibroblasts to secrete collagenases and pros-
taglandin E2 (PGE2)' (2, 3) . Additional inflammatory medi-
ators that have been detected either in situ or in synovial fluid
include IL6 (4, 5), IFN- ,y (6), transforming growth factor
a (TGF-f3) (7, 8), granuloryte/macrophage colony-stimulating
factor (GM-CSF) (9), platelet-derived growth factor (PDGF)
(10), and fibroblast growth factors (FGF) (10) . The precise
interplay of the diverse mediators in the pathophysiology of
chronic synovitis has yet to be elucidated .
'Abbreviations used in this paper. EGF, epidermal growth factor ; FGF,
fibroblast growth factor ; GM-CSF, granulocyte/macrophage colony-
stimulating factor ; PDGF, platelet-derived growth factor; PGE2, pros-
taglandin E2 ; TGF-0, transforming growth factor (3.
The infiltration and activation ofimmune cells within the
joint space occurs in many forms ofarthritis . In certain inflam-
matory arthritides such as rheumatoid arthritis, however, the
invasive and proliferative changes ofsynovial pannus become
a dominant feature. The degree to which the synovial fibroblast
contributes directly to these changes in unknown. Observa-
tions that may be relevant to this question include reports
that in vitro, rheumatoid synovial fibroblasts grow at a faster
rate and achieve a higher saturation density (11, 12) .
In the present study, we demonstrate that fibroblasts de-
rived fromhuman rheumatoid and chronic inflammatory sy-
novia continually produce inflammatory cytokines and growth
factors during long-term culture .
Materials and Methods
Isolation and Propagation ofSynovial Fibroblasts.
￿
Synovial fibro-
blasts were isolated from tissue obtained during reconstructive sur-
gery using established methods (13) . Cells were cultured in medium
consisting of80% DMEM, 10% NCTC-109 (Gibco Laboratories,
Grand Island, NY), 10% heat-inactivated FCS, ITS supplement
(Collaborative Research, Bedford, MA), and gentamicin (50 wg/ml) .
Cell cultures were trypsinized at -80% confluence and passaged
by a threefold division of cultures . At passage three (N2 wk for
rheumatoid cultures, and 2-3 wk for osteoarthritis cultures), sy-
novial fibroblast cultures were found to be completely free of lym-
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Giemsa staining)and specific immunostainingwith anti-CD2,CD3,
CD11b, andCD14mAbs (14, 15) . Contamination by mycoplasma
specieswas excluded by testing antibiotic-free culture supernatant
for adenosine phosphorylase activity (Mycotest; Gibco Laboratories) .
Synovial fibroblasts were derived from patients with the diag-
nosis of osteoarthritis (n = 7) and rheumatoid arthritis (n = 6)
(American Rheumatism Association Criteria [16]). Pathological ex-
amination revealed histopathological changes consistent with these
diagnoses . Inflammatory synovial fibroblasts were obtained from
patients (n = 4) with arthritic conditions other than rheumatoid
arthritis. These synoviashowed marked inflammatory cell infiltra-
tion on pathological examination .
Mitogenesis Assay .
￿
Synovial fibroblast-conditioned media was
generatedby growing cells at60% confluence in 2 ml of medium
containing 89% DME, 10% NCTC-109, and 1% FCS for 48 h.
For the assay of mitogenic factors, 96-well flat-bottomed micro-
titer plates were seeded with 0.1 ml of NIH-3T6 cells (4 x
103/ml) in DMEM and 10% FCS. After 48 h, the cells were
growth arrested by replacement of culture medium with DMEM
containing 1% FCS . 48 h later, this medium was aspirated
and 0.1 ml of synovial cell conditioned media added . 1 1sCi of
[3H]methyl-thymidine (2 Ci/mmol; New England Nuclear, Boston,
MA) was added after 24 h and incubation continued for an addi-
tional 30 h . The amount of [3H]thymidine incorporated into
DNA wasmeasured bycollecting cell lysatesonto glass fiber filters
(PhD cell harvester; CambridgeTechnology, Watertown,MA) and
analyzing radioactivityby liquid scintillation spectrometry. All assays
were performed in triplicate . Results are expressed as percent
[3H]thymidine incorporation relative to a 10% serum supple-
mented control, in which total incorporated radioactivity typically
ranged from 3,500 to 12,000 cpm.
Antibody Neutralization . The immunoglobulin fractions of
specific ,polyclonal antisera to the following human proteins were
used: anti-MIO (Genzyme,Boston, MA), anti-1L6 (R&DSystems,
Minneapolis, MN), anti-GM-CSF(R&DSystems), anti-epidermal
growth factor (EGF) (Collaborative Research), anti-basic FGF
(bFGF) (R & D Systems), antiTGF-Sl (the generous gift of Dr.
Martin Turner,The Charing Cross Sunley Research Center, London,
LJK) (17), and anti-PDGF (Genzyme) . For neutralization studies,
0.3 ml of conditioned mediawasincubated with specific antibodies
for 90 min at 37°C before the addition, in triplicate, of 0.1-ml
samples to the mitogenesis assay. Antibodies were titrated against
an "index"-conditioned media that displayed the highest level of
mitogenic activity and were subsequently used in excess of an
amount that maximally inhibited mitogenesis.
TNF/Cachectin Assay .
￿
TNF/Cachectin in.synovial fibroblast-
conditioned mediawasmeasured by specificELISA ofconcentrated
conditioned media (10x ) and by determining cytotoxicity for ac-
tinomycin D-treated L929 cells as described previously (18) .
Metabolic Labeling and Immunoprecipitation.
￿
Synovial fibroblasts
were grown to 50% confluence in 6-well plates and labeled with
0.5 mCi of"S-methionine (1,026 Ci/mmol; Trans3sS-Label; ICN,
Irvine,CA)following a standard protocol (19) . Equivalent amounts
of radioactive protein (determined byTCA precipitation) were then
incubated with specific antibody overnight at 4°C, followed by
incubation with protein-A Sepharose(Pharmacia Fine Chemicals,
Piscataway, NJ) . Protein-A Sepharose-bound material waswashed
sequentially in buffer containing 150mM NaCl, 20 mM Tris, pH
7.4, 2mM EDTA, 1% deoxycholate, 1% NP-40, 0.1% SDS, 0.2
mMPMSF (2 x), buffer containing 10mM Tris,pH 7.5,1% Triton
X-100 (2x), buffer containing 10mM Tris, pH 7.5, 1 M NaCl
(1x), and buffer containing 10mM Tris, pH 7.5, 0.1% SDS (1 x) .
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Washed resin wasresuspended in 75 P1 of Laemmlipolyacrylamide
gel electrophoresis sample buffercontaining dithiothreitol andheated
to 90°C for 2 min . 4-F,1 aliquots were analyzed for 3'S incorpora-
tion by liquid scintillation spectrometry. 25-w1 aliquots were sub-
jected to electrophoresis in 15% polyacrylamide mini-gels (19), and
radioactive proteins were analyzed by fluorography.
Results
Recent studies have reported an increased growth rate in
vitro of synovial fibroblasts derived from rheumatoid and
inflammatory arthropathieswhen compared with fibroblasts
derivedfrom noninflammatory arthropathies (11, 12) . Initial
studies of cell growth kinetics in our laboratory supported
these findings. To address the possibility that the increased
proliferative capacity ofrheumatoid synovial fibroblastsmight
be the result of an enhanced production ofautocrine growth
factors, a sensitive growth factor assay was used that tested
the ability of conditioned media to stimulate [3H]thymidine
incorporation in an "indicator" murine fibroblast cell line
(NIH-3T6) . Fig. 1 illustrates the result of this analysis for
17 synovial fibroblast lines derived from patients with os-
teoarthritis (n = 7), rheumatoid arthritis (n = 6), andinflam-
matory (nonrheumatoid) arthritis (n = 4) . It is apparent that
in contrast to the osteoarthritis synovial fibroblasts, fibro-
blasts derived from either inflammatory or rheumatoid sy-
novium constitutively produce soluble factors that stimulate
[3H]thymidine incorporation in murine fibroblasts.
Fig . 2 demonstrates that the growth stimulatory activity
of synovial fibroblast-conditioned media slowly diminishes
with passage number, however, significant activity persists
at passages 6-8 (corresponding to 8-12 wk in culture) . This
result complements ourobservations that synovial fibroblast
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Figure 1.
￿
Induction of [3H]thymidine incorporation in quiescent NIH-
3T6 cells by conditioned media obtained from seven osteoarthritis (OA),
four inflammatory arthritis (IA), and six rheumatoid arthritis (RA) syno-
vial fibroblast lines. Letters designate individual patient-derived cell tines,
and subscriptsdesignate the cell passage number at the time ofassay. 10%
and 1% refer to media containing either 10% or 1% FCS, which served
as positive and negative controls, respectively. Percent [3H]thymidine reefers
to incorporation induced by synovial fibroblast-conditioned media rela-
tive to the 10% serum supplement positive control . Error bars represent
the SEM of triplicate assays.50
Figure 2 .
￿
Diminution of the proliferative capacity ofconditioned media
from three rheumatoid synovial fibroblast lines (RA) and two inflamma-
tory arthritis synovial fibroblast lines (IA) as a function ofincreasing cell
passage number. Error bars represent the SEM of triplicate assay determi-
nations .
proliferation progressively decreases as a function of time in
culture (data not shown) . The growth-promoting effect of
synovial fibroblast-conditioned media was then studied in
a series of antibody neutralization experiments . Fig . 3 (left)
shows the effect of anticytokine antibody incubation on
[3H]thymidine incorporation for five of the rheumatoid sy-
novial fibroblast lines (rheumatoid arthritis) that were studied.
The proliferative capacity of this conditioned media was found
to be dependent on the presence ofEGF (4/5), bFGF (4/5),
TGF-01 (3/5), GM-CSF (3/5), and IIAO (5/5) . Evidence
against the possibility that these cytokines were unique to
rheumatoid arthritis was obtained by assaying media condi-
tioned by synovial fibroblasts obtained from three patients
with chronic, inflammatory arthritis that was clinically dis-
tinct from rheumatoid arthritis . In these cases, a similar pat-
tern of constitutive ;ytokine production was observed when
compared with the rheumatoid synovial fibroblast cells (EGF,
2/3 ; bFGF, 3/3 ; TGF-01, 3/3; GM-CSF,1/3 ; and IL-10, 3/3) .
In separate experiments, the production of cachectin/TNF
also was examined . This cytokine could not be detected in
any ofthe conditioned media tested by either a specificELISA
or by the L929 cell cytotoxicity assay (18) .
The synthesis of specific cytokines by synovial fibroblasts
was confirmed in vitro by metabolic labeling with 31S-me-
thionine. Quantitative immunoprecipitation with anti-bFGF,
antiTGF-01, anti-GM-CSF, and anti-IL1O antibodiesdemon-
strated increased synthesis of cytokines in inflammatory and
rheumatoid synovial fibroblast lines when compared with two
osteoarthritis fibroblast cell lines (Fig . 4) . Gel electrophoresis
and fluorography showed protein bands that correspond to
the molecular masses ofbFGF (N18W) (20), TGF-a (12.5
kD, monomer) (21), and IL1O (17.5 kD) (22) . Immunopre-
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Figure 3.
￿
Effect of specific antibody neutralization on the proliferative
capacity ofconditionedmedia from five rheumatoid(RA) and three inflam-
matory (IA) arthritis synovial fibroblast lines. Conditioned media was used
from the same passage number as shown in Fig. 1 . Error bars represent
the SEM of three to six assay determinations.
Figure 4 .
￿
Quantitative immunoprecipitation by specific antibody of
35S-labeled protein from two osteoarthritis (OA), one inflammatory (IA),
and one rheumatoid (RA) synovial fibroblast cell lines .
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Vcipitation studies with anti-EGF failed to demonstrate any
bands in the 7-8 kD (23) region, despite labeling to high
specific activity and prolonged exposure by fluorography (20
d) . We suggest that the inhibitory effect ofanti-EGF antiserum
on conditioned media in the 3T6 cell proliferation assay is
most likely due to the inactivation of EGF present in the
1% serum supplement in the assay (24) . 11,6, although not
implicated as a growth factor in the 3T6 fibroblast assay (Fig.
3), also was found to be synthesized in increased amounts
by inflammatory and rheumatoid synovial fibroblasts (Fig .
4) . This finding supports previous studies of enhanced 11'6
production by rheumatoid synoviocytes (25) .
Discussion
Media conditioned by fibroblasts cultured from rheuma-
toid and inflammatory synovia were found to stimulate
[3H]thymidine incorporation in an indicator fibroblast cell
line. Synovial fibroblasts derived from noninflammatory, os-
teoarthritis synovia did not display this property. This effect
appeared to represent a long-term, constitutive property of
synovial fibroblasts derived from rheumatoid and inflamma-
tory synovia because it occurred in the absence of immune
cells and persisted for >12 wk in culture. Antibody neutral-
ization and immunoprecipitation studies implicated a role for
bFGF, TGF-(31, GM-CSF, and I1-1# in the increased prolifer-
ative activity of synovial fibroblast-conditioned media .
IIAO production was observed in all the synovial fibro-
blast lines that were studied . This finding complements a
report of the spontaneous production of an I1,1-like factor
by cloned synovial cells (26) . The long-term, constitutive
production of Il-10 by synovial fibroblasts may perpetuate
an autocrine loop that continuously stimulates fibroblast mito-
genesis (27) . Even after the resolution of acute inflammatory
changes, fibroblast-derived I1-10 would promote synovial
hyperplasia as well as the continued recruitment and activa-
tion of additional infiltrating immune cells .
The other growth factors that were detected in synovial
fibroblast-conditioned media included bFGF, TGF-(31, and
GM-CSF. The induction of bFGF production by synovial
fibroblasts (28, 29) may promote neovascularization and con-
tribute further to the proliferative and invasive properties of
rheumatoid synovium . TGF-fit mediates a diverse set of bio-
logical functions (30) and has been detected within synovial
tissue in situ, particularly in areas of active fibrosis (8) . GM-
CSF activity was detected in two of the cell lines, and has
been implicated in the pathogenesis ofchronic inflammatory
synovitis in a previous study (9) . Of significance, GM-CSF
augments monocyte IL1 production, thus creating a posi-
tive feedback loop (31) . The observation that GM-CSF can
be produced autonomously in long-term synovial fibroblast
cultures further implicates synovial fibroblasts in a central
role in synovial inflammation, even after the egress of inflam-
matory cells (32) .
The antibody neutralization studies defined specific "cyto-
kine" profiles for eight synovial fibroblast lines . Cytokine
production by the inflammatory (nonrheumatoid) group did
not appear to differ significantly from the rheumatoid group.
The differences in the identity and the level of individual
cytokines that were detected in the synovial fibroblast lines
may reflect differential cytokine expression due to variations
in disease activity, concurrent antiinflammatory therapy, or
genetic background. These possibilities are under investiga-
tion ; however, variability in the level of specific cytokine
production points to the difficulties in attributing complex
inflammatory processes to single, dominantly acting inflam-
matory mediators . Cytokines interact and synergize in their
growth-promoting effects (27, 30, 31) . TGF-0 for example,
may exert either a proliferative or an antiproliferative effect,
depending on the interplay of additional growth factors (30) .
Synergy most likely accounts for the observation that in some
cases, the addition of more than one individual anticytokine
antibody inhibited proliferation by >50% .
A central question posed by our findings regards the mech-
anism by which synovial fibroblasts can be induced to un-
dergo such prolonged phenotypic changes that result in con-
stitutive cytokine production . One possibility is that the
infiltration of activated inflammatory cells and local produc-
tion of monocytic and lymphocytic inflammatory products
creates an appropriate milieu that drives synovial fibroblasts
into a long-term, activated state . The identity of such in-
citing products as well as the precise sequence of activation
is unknown at the present time. It is likely that monocytic
products such as TNF/cachectin, IFN-y, and macrophage-
inflammatory proteins (33), are involved in effecting fibro-
blast activation . The fibroblast, in turn, participates in the
inflammatory response by secreting the cytokines we have
described, as well as proteases, matrix proteins, and prosta-
glandins (1-3) . This scheme does not exclude the possibility
that constitutive differences in the responsiveness of synovial
fibroblasts to inflammatory mediators may exist, thus ren-
dering some individuals more susceptible to the sequelae of
chronic arthritis. The present study emphasizes the role of
the synovial fibroblast in modulatingjoint inflammation, and
suggests novel strategies for approaching the etiopathogen-
esis and therapy of some forms of chronic arthritis.
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